Clinical Trials Browser

Observational × Neoplasms × Influenza Vaccines × Clear all

NCT03061955 2024-10-04

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

Influenza, Human, Neoplasms